Healthcare

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing copper-based diagnostic and therapeutic products designed to target and treat cancer. The company's technology platform is built around the use of copper isotopes attached to targeting molecules that can identify and bind to specific markers …

Cochlear Ltd is a global leader in implantable hearing-solutions technology, best known for its cochlear-implant devices that restore hearing for individuals with severe to profound hearing loss. The company's products are used across a wide range of patient groups, from young children with congenital …

Telix Pharmaceuticals Ltd is a biopharmaceutical company focused on the development and commercialisation of radiopharmaceutical products used in the diagnosis and treatment of cancer and other serious diseases. The company's coreBusinessspans both diagnostic imaging agents and therapeutic radiopharmaceuticals, with its Precision Medicine division representing …

Ansell Ltd is a global leader in protective solutions, designing,Manufacturingand distributing products that protect people in industrial, healthcare and consumer settings. The company's product range spans protective gloves, clothing and other personal protective equipment used across a wide array of end markets, including healthcare, …

CSL (ASX:CSL) delivered one of the most challenging headline results in its recent history, reporting a significant statutory loss due to largeImpairmentcharges. However, investors focused on the underlyingBusinessperformance, improving plasma trends, cost reductions and FY27 guidance that suggested a return toward growth. The key …

Cochlear (ASX:COH) delivered a challenging FY26 result, with lower profit and a reduced dividend, but the market focused on improving operational momentum and a more constructive FY27 outlook. The company's second-half recovery, rapid adoption of the Nucleus Nexa System and continued growth in services …

Pro Medicus (ASX:PME) delivered another year of strong operational growth, supported by rising revenue, major healthcare contracts and industry-leading software margins. The company continues to expand its position in medical imaging technology, while new opportunities in reporting, artificial intelligence and adjacent healthcare areas could …